Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer.

Current pharmaceutical design - 1 Jan 2018

Moradi-Marjaneh Reyhaneh, Khazaei Majid, Seifi Sima, Hassanian Seyed Mahdi, Ferns Gordon A, Avan Amir

Abstract excerpt

Inter-individual differences in drug response are an important cause of failure in anticancer treatment and adverse drug events in cancer patients. Gene polymorphisms related to these outcomes have been investigated in an effort to find new genetic biomarkers to predict toxicity and response to anticancer drugs. Evaluating the value single nucleotide polymorphisms (SNPs) in the genes involved in transportation,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 30051785
DOI: 10.2174/1381612824666180727144535

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer.PMID 30051785Read ↗

Pharmacogenomics in colorectal cancer: The first step for individualized-therapySemantic proximity Read ↗

Pharmacogenetics of Drugs Used in the Treatment of CancersSemantic proximity Read ↗

Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.Semantic proximity Read ↗

Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents.Semantic proximity Read ↗

[SNPs associated with adverse effects].Semantic proximity Read ↗

Application of pharmacogenetics in oncologySemantic proximity Read ↗

Part 1: background, methodology, and clinical adoption of pharmacogenetics.Semantic proximity Read ↗

[Pharmacogenetics of anticancer drugs].Semantic proximity Read ↗

Cancer pharmacogeneticsSemantic proximity Read ↗

Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.